Guangzhou Sino-Israel Bio-Industry Investment Fund
Guangzhou, Guangdonggibf-bio.com
Overview
A Sino-Israeli investment fund established in 2016, focusing on cross-border investments in innovative biotech, drug development, and life sciences companies from Israel, Europe, and the USA that are in or approaching clinical stages and aspire to establish activities in China. The fund acts as a strategic partner, providing resources and networks for clinical trials, regulatory submissions, and commercialization in China.
Portfolio Companies
5
Website
gibf-bio.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Bioversys | Sep 2024 | Strategic | Lead |
| Nectin Therapeutics | May 2024 | VC Round | Co-investor |
| Bioversys | Jan 2023 | Series C Extension | - |
| Alpha Omega Engineering | Dec 2018 | VC Round | Lead |
| CarboFix Orthopedics | Mar 2016 | VC Round | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
